Healthcare Economics & Policy

Malpractice litigation is a risk that’s inherent to acute stroke care, Mount Sinai researchers reported in Stroke this month—and while just over half of cases get resolved, the remainder can cost medical centers millions in payouts.

It’s the fifth year in a row and the seventh year out of ten that compensation for cardiologists has increased, according to MedAxiom’s Cardiovascular Provider Compensation and Production Survey report.

Making the switch from analog insulin to older types of the drug can save patients money, INSIDER reports—but it can also be dangerous.

Biopharmaceutical company Renovacor, Inc., on August 14 announced it had raised $11 million in Series A financing to further develop its gene therapy-based treatments for CVD.

Illinois Gov. JB Pritzker signed House Bill 3435 this month, CNN reported—a law that will require insurance companies to cover all costs of EpiPen injections for anyone under 18 years old.

Health officials in the Midwest have confirmed at least 22 cases of vaping-related lung injury this month, according to recent reports, and are in the process of investigating as many as 18 more.

CMS this month announced that, after continued analysis of Abiomed’s Impella RP system, it will no longer be cutting its reimbursement rate for the heart pump in October.

Volunteers in Bend, Ore., are advocating for more widespread “Stop the Bleed” training after back-to-back mass shootings earlier this month left 31 dead, local paper the Bulletin reported August 11.

Corindus Vascular Robotics on August 8 announced it had entered a definitive merger agreement with Siemens Healthineers, which will reportedly acquire Corindus for a price of $1.1 billion.

Newly diagnosed HF patients with concomitant mitral regurgitation can expect more admissions, longer hospital stays and pricier medical bills than HF patients without MR, according to an analysis published in the American Journal of Cardiology.

A court case from half a decade ago reemerged this month after Kentucky-based cardiologists Satyabrata Chatterjee and Ashwini Anand filed a lawsuit against CBS, which featured their case in an August 2018 episode of “Whistleblower."

The FDA has granted B. Braun Interventional Systems Inc. breakthrough device designation for its SeQuent Please ReX drug-coated PTCA balloon catheter, the company announced August 1.